Your weekly roundup of the latest news from Drug Topics®.
With supply chain issues impacting many industries, drug shortages have occurred. How does the FDA address them?
Israeli researchers find more than fivefold risk of developing systemic sclerosis among people with vitiligo.
New research indicates that glucose monitoring could lead to lifestyle changes during prediabetes.
Addressing the 2 inflammatory conditions requires careful consideration of the therapies to use.
This is the first FDA-approved ADC for platinum-resistant disease, according to ImmunoGen.